AbbVie (NYSE:ABBV) is scheduled to announce Q2 earnings results on Friday, July 26th, before market open.
The consensus EPS Estimate is $2.21 (+10.5% Y/Y) and the consensus Revenue Estimate is $8.09B (-2.3% Y/Y).
Over the last 2 years, ABBV has beaten EPS estimates 88% of the time and has beaten revenue estimates 75% of the time.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.